Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001821825-24-000110
Filing Date
2024-11-08
Accepted
2024-11-08 16:17:43
Documents
1
Period of Report
2024-11-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1731100655.html 4  
1 FORM 4 wk-form4_1731100655.xml 4 7222
  Complete submission text file 0001821825-24-000110.txt   8775
Mailing Address C/O MYOVANT SCIENCES INC. 2000 SIERRA POINT PARKWAY, 9TH FLOOR BRISBANE CA 94005
Business Address
Arjona Ferreira Juan Camilo (Reporting) CIK: 0001714080 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40235 | Film No.: 241440856

Mailing Address 30 HUDSON STREET FL 33 JERSEY CITY NJ 07302
Business Address 30 HUDSON STREET FL 33 JERSEY CITY NJ 07302 551-430-6000
Organon & Co. (Issuer) CIK: 0001821825 (see all company filings)

EIN.: 464838035 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)